I spoke to a source with Major League Baseball this afternoon who tells me that MLB will investigate Curt Schilling’s claim on ESPN radio yesterday afternoon that a Boston Red Sox employee told him he should take PEDs when he was suffering from shoulder trouble in 2008.
The source did not say what, exactly, would be done, but it’s hard to see how any investigation of this claim does not begin with Schilling himself. Earlier today Schilling said he would not identify who told him to take PEDs in 2008. It will be interesting to see if he is any more forthcoming to the league.
Meanwhile, Sean McAdam of CSNNE.com spoke with a source who thinks Schilling is making a mountain out of a molehill:
… a source familiar with the situation said, “I’m sure if anyone said something like that, it wasn’t meant to be serious. I would bet my bottom dollar on that.”
Also this afternoon, Evan Drellich of MLB.com reported that team president/CEO Larry Lucchino said that the Boston Red Sox will look into the claim itself. As Schilling noted in his interview, however, the person is no longer employed by the Red Sox.
Baseball news has been dominated by drug stories for the past week and change. It looks like it will continue to be so dominated for a while longer. But it is worth observing that Major League Baseball seems as serious about investigating an allegation relating to team personnel and PEDs as it is in investigating players who allegedly used. Which is a good thing.
The Diamondbacks have signed free agent left-hander Jorge De La Rosa to a minor league deal, per a team announcement on Sunday. The contract includes an invitation to spring training. Nick Piecoro of AZCentral.com adds that De La Rosa stands to make $2.25 million if he secures a spot on the major league roster, with up to $600,000 in incentives if he pitches out of the bullpen and up to $1 million in incentives if he pitches out of the starting rotation.
The 35-year-old is expected to compete for a bullpen role after spending the better part of a decade in the Rockies’ rotation. He capped a nine-year run with Colorado in 2016, finishing the year with a 5.51 ERA, 4.2 BB/9 and 7.3 SO/9 over 134 innings. Despite his struggles out of the rotation, he found limited success in a three-game stint in the bullpen, striking out 10 of 26 batters and holding the opposition to just three hits and one earned run in eight innings.
The veteran lefty is set to join a bullpen comprised of right-handers Randall Delgado, Jake Barrett and Fernando Rodney, along with a number of unproven candidates on similar minor league contracts. His age and command issues may be off-putting, but the promise he showed as a reliever should give the Diamondbacks some upside as they attempt to redeem a league-worst bullpen in 2017.
Blue Jays’ third baseman Josh Donaldson is expected to miss up to three weeks with a right calf strain, reports John Lott. Donaldson reportedly felt some discomfort in his calf during sprinting drills on Friday and was diagnosed with what looked like a mild strain after undergoing an MRI on Saturday. According to Lott, the 31-year-old is on crutches for the next few days and will likely miss 2-3 weeks of spring training.
Donaldson had a similar scare at the start of the 2016 season, when he limped out of the batter’s box during the Blue Jays’ first regular season road trip with a right calf strain. He returned to DH two days later, however, and was back on the field in less than a week’s time. Blue Jays’ GM Ross Atkins told MLB.com’s Corey Long that the two calf injuries are unrelated, and expects that Donaldson will recover in similar fashion this spring — well before Opening Day comes around.